CAS: 196808-45-4 - 2(S)-(2-Benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenyl]propionic acid
Formule :C34H30N2O5
InChI :InChI=1S/C34H30N2O5/c1-23-29(36-33(41-23)26-12-6-3-7-13-26)20-21-40-27-18-16-24(17-19-27)22-31(34(38)39)35-30-15-9-8-14-28(30)32(37)25-10-4-2-5-11-25/h2-19,31,35H,20-22H2,1H3,(H,38,39)/t31-/m0/s1
Code InChI :InChIKey=ZZCHHVUQYRMYLW-HKBQPEDESA-N
SMILES :O=C(O)C(NC=1C=CC=CC1C(=O)C=2C=CC=CC2)CC3=CC=C(OCCC=4N=C(OC4C)C=5C=CC=CC5)C=C3
- Synonymes :
- <span class="text-smallcaps">L</span>-Tyrosine, N-(2-benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-
- Farglitazar
- G1 262570
- Gi 262570X
- Gi-262570
- N-(2-Benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-<span class="text-smallcaps">L</span>-tyrosine
- N-(2-Benzoylphenyl)-O-[4-[2-(5-methyl-2-phenyloxazol-4-yl)ethyl]-L-tyrosine
- N-(2-benzoylphenyl)-O-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl]-L-tyrosine
Marque | Informations sur le produit | Degré de pureté | Gamme de prix | Livraison estimée |
---|---|---|---|---|
N-(2-Benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-L-tyrosine REF : TR-F102370CAS : 196808-45-4 | - - - | 2.134,00 € | ven 27 Déc 24 | |
Farglitazar REF : 3D-WHA80845CAS : 196808-45-4 | Min. 95% | À demander | ven 27 Déc 24 | |
Farglitazar REF : TM-T27303CAS : 196808-45-4 | 99.40% - 99.65% | 276,00 €~1.862,00 € | jeu 02 Jan 25 |
N-(2-Benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-L-tyrosine
Produit contrôléRef: TR-F102370
750mg | 2.134,00 € |
Farglitazar
Ref: 3D-WHA80845
25mg | À demander | ||
50mg | À demander | ||
100mg | À demander | ||
250mg | À demander | ||
500mg | À demander |
Farglitazar
Ref: TM-T27303
1mg | 276,00 € | ||
5mg | 679,00 € | ||
10mg | 928,00 € | ||
25mg | 1.430,00 € | ||
50mg | 1.862,00 € |